Cart
sales@molnova.com
GSK2879552 2HCl
CAS No. ——
GSK2879552 2HCl ( —— )
Catalog No. M17707 CAS No. ——
GSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 109 | Get Quote |
|
| 10MG | 182 | Get Quote |
|
| 25MG | 303 | Get Quote |
|
| 50MG | 426 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK2879552 2HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
-
DescriptionGSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetJNK
-
RecptorLSD1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight437.41
-
Molecular FormulaC23H30Cl2N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.O=C(O)c1ccc(cc1)CN2CCC(CC2)CN[C@@H]4C[C@H]4c3ccccc3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huang M,etal..Cancer Lett. 2017 Jul 10;398:12-21.
molnova catalog
related products
-
AS601245.2TFA
AS601245.2TFA is a cell-permeable Inhibitor of JNK (IC50s of 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively).
-
6-CFDA N-succinimidy...
The succinimidyl ester group is capable of spontaneously and irreversibly binding to free amines. Utilized in flow cytometry experiments for tracking cell division in both mammalian cells and bacteria.
-
[D-Arg1,D-Phe5,D-Trp...
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradykinin, CCK and bombesin receptors. Induces apoptosis and inhibits cancer cell growth in vitro.
